About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy

NCT02805153·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with age between 18 and 70 years
diagnosis of breast cancer patients
chemotherapy naive
Karnofsky Performance Status ≥ 70
Written informed consent are acquired

You may not be if

uncontrolled infection
Have accepted radiotherapy within 4 weeks before anticipated the study
pregnancy
Other situations that investigators consider as contra-indication for this study

The record

StatusCompleted

PhasePhase 4

Taking part215

StartedApr 2013

UpdatedJun 20, 2016

Conditions

Clareo Health | PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy